Bli medlem
Bli medlem

Du är här

2015-12-16

Probi: New product format for Probi Digestis® targeting kids segment

Probi's partner, Sanofi, is launching Cenovis Kids Superbiotics in
South Korea. Cenovis Kids Superbiotics, based on Probi Digestis, a
combination of probiotics and prebiotics is launched as a new product
application. The new format, a powder stick, is a convenient solution
targeting a new market segment, the kids segment. [image]

The new Probi Digestis®stick-pack product is a fast-melt powder that
can be poured straight into the mouth, without the need of mixing it
with water. The product is convenient and easy for kids to consume,
and comes in a nice strawberry flavor.

Probi Digestis®is based on Lactobacillus plantarum 299v (DSM 9843),
Probi's most well-documented bacterial strain. More than 30 human
studies have been conducted with this strain, with a focus on
gastrointestinal health.

Successful partnership

Probi and Sanofi established partnership in 2014, with a distribution
and supply agreement under which the Consumer Healthcare division of
Sanofi South Korea sells Probi's gut health product, Probi Digestis®.
In South Korea, the product is marketed under the brand name Cenovis
Superbiotics. Cenovis Kids is a line extension of this product and is
aimed for children in the ages between 4-10 years old.

"After the successful launch of Cenovis Superbiotics, Sanofi is
strengthening its product portfolio with Cenovis Kids. It is very
positive that Sanofi is expanding their probiotic range and it shows
their commitment to Probi's well-documentet probiotic strains," says
Linda Neckmar, Director of Marketing & Sales Consumer Healthcare at
Probi.

Nationwide campaign

Sanofi is launching an extensive nationwide campaign for the new kids
product in South Korea. The product is being sold in department
stores, duty free and on-line, reaching out to potential customers
through a mix of advertising, PR, retail promotion, sampling and
on-line marketing.

FOR FURTHER INFORMATION, CONTACT:
Niklas Bjärum, VP Marketing & Sales, Probi, tel +46 46 286 89 67 or
mobile +46 705 38 88 64, e-mail:
(niklas.bjarum@probi.se)niklas.bjarum@probi.se
(niklas.bjarum@probi.se)

Linda Neckmar, Director M&S, Consumer Healthcare, Probi, tel +46 46
286 89 71 or mobile +46 733 47 71 71, e-mail:
(niklas.bjarum@probi.se)linda.neckmar@probi.se

ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company that
develops effective and well-documented probiotics. Through its
world-leading research, Probi has created a strong product portfolio
in the gastrointestinal health and immune system niches. Probi's
products are available to consumers in more than 30 countries
worldwide. Probi's customers are leading food, health- product and
pharmaceutical companies in the Functional Food and Consumer
Healthcare segments. In 2014, Probi had sales of MSEK 135. The Probi
share is listed on NASDAQ OMX Stockholm, Small Cap. Probi has about
3,500 shareholders. Read more at www.probi.se.

-----------------------------------------------------------
http://news.cision.com/probi/r/new-product-format-for-probi-digestis--ta...
http://mb.cision.com/Main/1556/9885677/457607.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.